Literature DB >> 18497312

An inconvenient truth: recognizing individual differences in arteriogenesis.

Jalees Rehman.   

Abstract

Mesh：

Year:  2008        PMID： 18497312      PMCID： PMC2764358          DOI： 10.1161/CIRCRESAHA.108.177311

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  14 in total

Review 1.  Angiogenesis in health and disease.

Authors:  Peter Carmeliet
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

2.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

Review 3.  Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis.

Authors:  Stephen E Epstein; Eugenio Stabile; Timothy Kinnaird; Cheol Whan Lee; Leonardo Clavijo; Mary Susan Burnett
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

Review 4.  Moving towards individualized medicine with pharmacogenomics.

Authors:  William E Evans; Mary V Relling
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

5.  The aspirin resistance controversy: clinical entity or platelet heterogeneity?

Authors:  Jane E Freedman
Journal:  Circulation       Date:  2006-06-27       Impact factor: 29.690

6.  Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.

Authors:  M Arras; W D Ito; D Scholz; B Winkler; J Schaper; W Schaper
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.

Authors:  Y A Sidky; E C Borden
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

8.  Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.

Authors:  Stephan H Schirmer; Joost O Fledderus; Pieter T G Bot; Perry D Moerland; Imo E Hoefer; Jan Baan; José P S Henriques; René J van der Schaaf; Marije M Vis; Anton J G Horrevoets; Jan J Piek; Niels van Royen
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

Review 9.  Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.

Authors:  Ahmed Abdel-Latif; Roberto Bolli; Imad M Tleyjeh; Victor M Montori; Emerson C Perin; Carlton A Hornung; Ewa K Zuba-Surma; Mouaz Al-Mallah; Buddhadeb Dawn
Journal:  Arch Intern Med       Date:  2007-05-28

Review 10.  Interferon: cellular executioner or white knight?

Authors:  S G Maher; A L Romero-Weaver; A J Scarzello; A M Gamero
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530
View more
  4 in total

1.  Blocking interferon {beta} stimulates vascular smooth muscle cell proliferation and arteriogenesis.

Authors:  Stephan H Schirmer; Pieter T Bot; Joost O Fledderus; A M van der Laan; Oscar L Volger; Ulrich Laufs; Michael Böhm; Carlie J M de Vries; Anton J G Horrevoets; Jan J Piek; Imo E Hoefer; Niels van Royen
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

2.  Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway.

Authors:  Yanmin Zhang; Brittney-Shea Herbert; Gangaraju Rajashekhar; David A Ingram; Mervin C Yoder; Matthias Clauss; Jalees Rehman
Journal:  FASEB J       Date:  2009-01-05       Impact factor: 5.191

3.  Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells.

Authors:  Yanmin Zhang; David A Ingram; Michael P Murphy; M Reza Saadatzadeh; Laura E Mead; Daniel N Prater; Jalees Rehman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-27       Impact factor: 4.733

4.  Vascular growth in health and disease.

Authors:  Anja Bondke Persson; Ivo R Buschmann
Journal:  Front Mol Neurosci       Date:  2011-08-24       Impact factor: 5.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.